Alnylam Pharmaceuticals (ALNY.MX) Q1 2026 Earnings

Feb 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-17.44
-0.26
16.91
34.09

Details

Expected EPS
19.8983548995
Actual EPS
14.115848999999999
Surprise EPS
-5.78
Surprise Percent
-29.06%

Description

⁨Alnylam Pharmaceuticals⁩ (⁦ALNY.MX⁩) has reported earnings of ⁦14.115848999999999⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts